Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
BPC-157 Arginate vs Vesugen
An educational, source-based comparison of BPC-157 Arginate and Vesugen — how each peptide works, what it's researched for, and what to know before going deeper.
Stabilized salt form of BPC-157 with enhanced stability.
An arginate salt formulation of BPC-157 designed to improve stability and shelf-life. Research suggests the same angiogenic, anti-inflammatory, and tissue-repair mechanisms as standard BPC-157, with potentially improved bioavailability.
- Tendon and ligament healing
- Gastric ulcer protection
- Neuroprotection and nerve repair
- Systemic anti-inflammatory effects
- • Same cautions as standard BPC-157: preclinical data, not FDA-approved.
- • Quality of compounded formulations varies widely.
A synthetic tripeptide (Lys-Glu-Asp) in the Khavinson bioregulator family. Research indicates modulation of endothelial cell function and vascular wall gene expression, supporting vascular tone and microcirculation.
- Vascular endothelial function
- Microcirculation in aging
- Peripheral vascular disorders
- • Russian-origin research; independent replication limited.
- • Not FDA-approved.
BPC-157 Arginate vs Vesugen — Key differences
- Class: BPC-157 Arginate is classified as Tissue Repair · Gastrointestinal, while Vesugen is Vascular · Bioregulator.
- Primary research focus: BPC-157 Arginate — tendon and ligament healing; Vesugen — vascular endothelial function.
- Tag: Recovery vs Vascular · Bioregulator.